Inhalers and Steroid Medications Change Brain Matter

Introduction

The use of prescribed steroids, including in inhalers, is linked to changes in the structure and volume of white and grey matter in the brain, suggests the findings of the most extensive study of its kind, published in the open access journal BMJ Open.

Main Item

The associations found might help to explain the neuropsychiatric effects, such as anxiety, depression, mania, and delirium, frequently seen after long-term use, say the researchers.

Their immunosuppressive properties mean that glucocorticoids, a class of synthetic steroids, are among some of the most frequently prescribed drugs. They are used to treat a wide variety of medical conditions.

The estimated annual population prevalence in high-income countries of systemic (infusions and tablets) medical steroid use is thought to range between 0.5% and 3%.

While very effective, systemic and inhaled steroids are associated with many potentially serious metabolic, cardiovascular, and musculoskeletal side and neuropsychiatric effects.

Previously published research suggests long-term medical steroid use is associated with structural abnormalities and shrinkage of certain brain areas. But most of these studies have involved only small numbers of people with specific conditions.

And it's still not clear if these associations might also be observed in a broader sample of medical steroid users, including those using inhaled steroids for respiratory conditions, such as asthma.

In a bid to find out, the researchers drew on data from the UK Biobank, comprising half a million 40-69 year-olds from the general population, to see if there were any detectable differences in brain volume and structure between users and non-users of systemic and inhaled steroids.

The researchers also wanted to know if steroid use might be associated with differences in processing speed and emotional responses.

The MRI brain scans of 222 people using systemic steroids and 557 using inhaled steroids were compared with those of 24,106 non-users.

None of the study participants had previously been diagnosed with neurological, psychiatric, or hormonal (endocrinological) disorders or were taking mood-altering drugs, such as antidepressants.

Participants filled in a questionnaire to assess certain aspects of mood over the previous fortnight.

Comparison of the MRI scan results showed that systemic and inhaled steroid use was associated with less intact white matter structure than was seen on those scans, not on these drugs. White matter has a role in neuronal connectivity and signaling in the brain.

The effects were greater in systemic users than in users of inhaled steroids. And further detailed analysis suggested that the effects might be even larger among long-term users.

Systemic use was associated with a larger caudate compared with no use, while the use of inhaled steroids was associated with a smaller amygdala. The caudate and amygdala are grey matter structures in the brain involved in cognitive and emotional processing.

Systemic steroid users also performed worse on a test designed to measure processing speed than non-users. They reported significantly more depressive symptoms, apathy, restlessness, and fatigue/lethargy than non-users. Inhaled steroid users reported only more tiredness/lethargy, and to a lesser degree than systemic steroid users.

"Although a causal relationship between glucocorticoid use and changes in the brain is likely based on the present and previous studies, the cross-sectional nature of this study does not allow for formal conclusions on causality," caution the researchers.

They also point to certain limitations.

Only a few indicators of mood change were assessed, and only for the preceding two weeks. The reported changes might have been related to the condition for which steroids were prescribed rather than to steroid use.

Nor were the researchers able to differentiate between steroid tablets and infusions for systemic users, all of which may have influenced the findings.

But they write:

"While it remains unclear whether the observed effect sizes have clinical consequences for the population of glucocorticoid users as a whole, these findings are remarkable given the common neuropsychiatric side effects of synthetic glucocorticoids."

And they conclude:

"This study shows that both systemic and inhaled glucocorticoids are associated with a widespread reduction in white matter integrity, which may in part underlie the neuropsychiatric side effects observed in patients using glucocorticoids."

Given how widely used these drugs are, doctors and patients need to know about the possible effects on the brain, say the researchers, who now call for research into alternative treatment options.

Attribution/Source(s):

This peer reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by BMJ, and published on 2022/08/31 (Edit Update: 2023/01/04), the content may have been edited for style, clarity, or brevity. For further details or clarifications, BMJ can be contacted at bmj.com. NOTE: Disabled World does not provide any warranties or endorsements related to this article.

Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): BMJ. (2022, August 31 - Last revised: 2023, January 4). Inhalers and Steroid Medications Change Brain Matter. Disabled World. Retrieved December 12, 2024 from www.disabled-world.com/health/neurology/brain/steroid-meds.php

Permalink: <a href="https://www.disabled-world.com/health/neurology/brain/steroid-meds.php">Inhalers and Steroid Medications Change Brain Matter</a>: The associations found might help to explain the neuropsychiatric effects, such as anxiety, depression, mania, and delirium frequently seen after long-term use.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.